T. Rowe Price Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $105M | Sell |
2,886,268
-332,674
| -10% | -$12.1M | 0.01% | 561 |
|
|
2025
Q1 | $117M | Buy |
3,218,942
+706,519
| +28% | +$25.6M | 0.01% | 522 |
|
|
2024
Q4 | $106M | Sell |
2,512,423
-556,231
| -18% | -$23.4M | 0.01% | 558 |
|
|
2024
Q3 | $170M | Buy |
3,068,654
+76,696
| +3% | +$4.26M | 0.02% | 463 |
|
|
2024
Q2 | $123M | Sell |
2,991,958
-576,915
| -16% | -$23.7M | 0.01% | 501 |
|
|
2024
Q1 | $167M | Buy |
3,568,873
+120,175
| +3% | +$5.61M | 0.02% | 455 |
|
|
2023
Q4 | $165M | Buy |
3,448,698
+288,538
| +9% | +$13.8M | 0.02% | 441 |
|
|
2023
Q3 | $113M | Sell |
3,160,160
-454,832
| -13% | -$16.2M | 0.02% | 490 |
|
|
2023
Q2 | $167M | Buy |
3,614,992
+71,231
| +2% | +$3.29M | 0.02% | 424 |
|
|
2023
Q1 | $142M | Sell |
3,543,761
-552,627
| -13% | -$22.2M | 0.02% | 449 |
|
|
2022
Q4 | $190M | Sell |
4,096,388
-660,568
| -14% | -$30.6M | 0.03% | 388 |
|
|
2022
Q3 | $197M | Sell |
4,756,956
-6,023,200
| -56% | -$249M | 0.03% | 364 |
|
|
2022
Q2 | $643M | Sell |
10,780,156
-1,104,630
| -9% | -$65.9M | 0.08% | 239 |
|
|
2022
Q1 | $863M | Buy |
11,884,786
+359,697
| +3% | +$26.1M | 0.09% | 229 |
|
|
2021
Q4 | $969M | Buy |
11,525,089
+66,043
| +0.6% | +$5.55M | 0.09% | 231 |
|
|
2021
Q3 | $1.03B | Buy |
11,459,046
+459,832
| +4% | +$41.5M | 0.1% | 216 |
|
|
2021
Q2 | $1.05B | Buy |
10,999,214
+327,428
| +3% | +$31.2M | 0.1% | 220 |
|
|
2021
Q1 | $1.22B | Buy |
10,671,786
+1,201,294
| +13% | +$137M | 0.12% | 188 |
|
|
2020
Q4 | $1.31B | Buy |
9,470,492
+1,121,763
| +13% | +$155M | 0.13% | 165 |
|
|
2020
Q3 | $686M | Buy |
8,348,729
+682,112
| +9% | +$56.1M | 0.08% | 254 |
|
|
2020
Q2 | $600M | Buy |
7,666,617
+2,957,795
| +63% | +$231M | 0.08% | 265 |
|
|
2020
Q1 | $209M | Buy |
4,708,822
+217,053
| +5% | +$9.64M | 0.03% | 398 |
|
|
2019
Q4 | $192M | Buy |
4,491,769
+36,184
| +0.8% | +$1.55M | 0.02% | 490 |
|
|
2019
Q3 | $191M | Sell |
4,455,585
-156,354
| -3% | -$6.69M | 0.03% | 458 |
|
|
2019
Q2 | $293M | Buy |
4,611,939
+1,110,316
| +32% | +$70.5M | 0.04% | 377 |
|
|
2019
Q1 | $243M | Buy |
3,501,623
+771,242
| +28% | +$53.5M | 0.04% | 415 |
|
|
2018
Q4 | $119M | Sell |
2,730,381
-47,648
| -2% | -$2.07M | 0.02% | 565 |
|
|
2018
Q3 | $212M | Sell |
2,778,029
-18,363
| -0.7% | -$1.4M | 0.03% | 473 |
|
|
2018
Q2 | $215M | Buy |
2,796,392
+544,691
| +24% | +$41.9M | 0.03% | 453 |
|
|
2018
Q1 | $115M | Buy |
2,251,701
+130,846
| +6% | +$6.67M | 0.02% | 607 |
|
|
2017
Q4 | $98.4M | Buy |
2,120,855
+496,135
| +31% | +$23M | 0.02% | 644 |
|
|
2017
Q3 | $86.5M | Sell |
1,624,720
-136,869
| -8% | -$7.29M | 0.01% | 662 |
|
|
2017
Q2 | $109M | Buy |
1,761,589
+90,765
| +5% | +$5.64M | 0.02% | 570 |
|
|
2017
Q1 | $113M | Buy |
1,670,824
+1,317
| +0.1% | +$89.3K | 0.02% | 564 |
|
|
2016
Q4 | $117M | Sell |
1,669,507
-158,100
| -9% | -$11.1M | 0.02% | 550 |
|
|
2016
Q3 | $130M | Buy |
1,827,607
+235,630
| +15% | +$16.7M | 0.03% | 517 |
|
|
2016
Q2 | $77.9M | Buy |
1,591,977
+242,340
| +18% | +$11.9M | 0.02% | 646 |
|
|
2016
Q1 | $85.4M | Sell |
1,349,637
-1,750
| -0.1% | -$111K | 0.02% | 596 |
|
|
2015
Q4 | $152M | Sell |
1,351,387
-7,568
| -0.6% | -$849K | 0.03% | 457 |
|
|
2015
Q3 | $131M | Buy |
1,358,955
+179,815
| +15% | +$17.3M | 0.03% | 509 |
|
|
2015
Q2 | $121M | Sell |
1,179,140
-66,700
| -5% | -$6.83M | 0.02% | 551 |
|
|
2015
Q1 | $77.4M | Sell |
1,245,840
-70,300
| -5% | -$4.36M | 0.02% | 690 |
|
|
2014
Q4 | $57.8M | Sell |
1,316,140
-750
| -0.1% | -$32.9K | 0.01% | 797 |
|
|
2014
Q3 | $74.5M | Buy |
1,316,890
+63,611
| +5% | +$3.6M | 0.02% | 692 |
|
|
2014
Q2 | $53.7M | Sell |
1,253,279
-137,700
| -10% | -$5.9M | 0.01% | 842 |
|
|
2014
Q1 | $65.2M | Buy |
+1,390,979
| New | +$65.2M | 0.01% | 773 |
|